ArticleBMJ open2025
Instruments for measuring fatigue in patients with brain tumours: protocol for a COSMIN--based systematic review.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCancer-related fatigue occurs at high rates and can harm patients' quality of life and even reduce survival, especially in patients with brain tumours. Many measures have been developed to assess this condition, but there have been no systematic reviews evaluating the metrological properties of these tools, and it is difficult to determine the measures with optimal properties and the conditions under which they should be applied. Therefore, we need to collect existing evidence and choose the most reasonable instrument. Our aim is to identify all instruments used to measure fatigue in patients with brain tumours and identify gaps in them by assessing measurement properties and methodological quality. METHODS AND ANALYSIS: This protocol follows the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 checklist. Future systematic review reports will be based on the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines and patient-reported outcome measures (PROMs) and PRISMA 2020 statement guidelines. Five databases (PubMed, CINAHL, PsycARTICLES, Embase and Ovid MEDLINE) will be searched between 1 January 2025 and 31 January 2025 to screen for instruments assessing fatigue in patients with brain tumours. Two researchers will independently complete literature screening, data extraction and literature evaluation, and any differences will be resolved through discussion with the participation of a third researcher. The methodological quality and instrument characteristics of included studies will be assessed according to COSMIN risk of bias guidelines. ETHICS AND DISSEMINATION: Ethical approval is not applicable. We will disseminate the findings from the study at national and/or international conferences and in a peer-reviewed journal in the fields of oncology nursing and/or neurosurgery. PROSPERO REGISTRATION NUMBER: CRD42024530318.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.